Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis | 6 | 2011 | 953 | 0.820 |
Why?
|
Pre-Eclampsia | 3 | 2024 | 1227 | 0.710 |
Why?
|
Activin Receptors, Type II | 1 | 2019 | 124 | 0.620 |
Why?
|
Tissue Engineering | 7 | 2010 | 1870 | 0.580 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 898 | 0.530 |
Why?
|
Heart Failure | 6 | 2024 | 11593 | 0.490 |
Why?
|
Myocardium | 5 | 2024 | 4690 | 0.450 |
Why?
|
Tissue Scaffolds | 5 | 2011 | 926 | 0.450 |
Why?
|
Bone Marrow Cells | 4 | 2010 | 2414 | 0.430 |
Why?
|
Aging | 4 | 2020 | 8650 | 0.410 |
Why?
|
Cardiomyopathies | 1 | 2024 | 1944 | 0.400 |
Why?
|
Heart Diseases | 1 | 2024 | 2782 | 0.370 |
Why?
|
Physical Conditioning, Animal | 2 | 2022 | 364 | 0.310 |
Why?
|
Stroke Volume | 3 | 2021 | 5460 | 0.300 |
Why?
|
Blood Vessels | 2 | 2011 | 1112 | 0.290 |
Why?
|
Exercise | 2 | 2020 | 5788 | 0.270 |
Why?
|
Coated Materials, Biocompatible | 1 | 2007 | 312 | 0.250 |
Why?
|
Bioprosthesis | 2 | 2008 | 591 | 0.220 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2010 | 1426 | 0.210 |
Why?
|
Peripartum Period | 1 | 2024 | 137 | 0.210 |
Why?
|
Boidae | 1 | 2022 | 14 | 0.210 |
Why?
|
Polyglycolic Acid | 3 | 2008 | 405 | 0.200 |
Why?
|
Stromal Cells | 1 | 2007 | 1326 | 0.200 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1655 | 0.200 |
Why?
|
Polyesters | 3 | 2007 | 371 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2024 | 930 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 557 | 0.180 |
Why?
|
Heart | 3 | 2020 | 4382 | 0.160 |
Why?
|
Signal Transduction | 2 | 2020 | 23342 | 0.160 |
Why?
|
Follistatin-Related Proteins | 1 | 2019 | 48 | 0.160 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.160 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 517 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1561 | 0.150 |
Why?
|
Activins | 1 | 2019 | 211 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1066 | 0.140 |
Why?
|
Mice, SCID | 4 | 2010 | 2626 | 0.140 |
Why?
|
Ventricular Remodeling | 1 | 2024 | 1256 | 0.140 |
Why?
|
Systole | 1 | 2019 | 936 | 0.140 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2017 | 141 | 0.140 |
Why?
|
Sheep | 3 | 2008 | 1441 | 0.130 |
Why?
|
Animals | 17 | 2024 | 167768 | 0.130 |
Why?
|
Surgical Mesh | 3 | 2008 | 311 | 0.130 |
Why?
|
Mice | 12 | 2024 | 81101 | 0.130 |
Why?
|
Pressure | 1 | 2019 | 1155 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 781 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1097 | 0.120 |
Why?
|
Biocompatible Materials | 3 | 2008 | 1688 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2009 | 686 | 0.120 |
Why?
|
Placenta | 1 | 2024 | 1702 | 0.120 |
Why?
|
Cells, Cultured | 6 | 2017 | 18940 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2007 | 3533 | 0.110 |
Why?
|
Interferon Type I | 1 | 2017 | 559 | 0.110 |
Why?
|
Models, Animal | 4 | 2022 | 2112 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1312 | 0.100 |
Why?
|
Ligands | 1 | 2019 | 3258 | 0.100 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2378 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2011 | 88 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22003 | 0.090 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2010 | 167 | 0.080 |
Why?
|
Hydroxyproline | 1 | 2007 | 110 | 0.080 |
Why?
|
Dioxanes | 1 | 2007 | 36 | 0.080 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2010 | 940 | 0.080 |
Why?
|
Pregnancy | 3 | 2024 | 29742 | 0.080 |
Why?
|
Centrifugation | 1 | 2007 | 122 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15785 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 604 | 0.070 |
Why?
|
Porosity | 1 | 2007 | 349 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2010 | 360 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2019 | 3806 | 0.070 |
Why?
|
Cell Culture Techniques | 2 | 2010 | 1664 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11070 | 0.060 |
Why?
|
Monocytes | 2 | 2018 | 2570 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12094 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18119 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 66 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5737 | 0.050 |
Why?
|
Rats | 1 | 2019 | 23679 | 0.050 |
Why?
|
Lactic Acid | 1 | 2007 | 1133 | 0.050 |
Why?
|
Thymidine | 1 | 2022 | 299 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16534 | 0.050 |
Why?
|
Humans | 15 | 2024 | 758406 | 0.050 |
Why?
|
Calcineurin | 1 | 2022 | 229 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2010 | 11471 | 0.050 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2024 | 478 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 260 | 0.050 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2022 | 239 | 0.050 |
Why?
|
Polymers | 1 | 2007 | 1616 | 0.040 |
Why?
|
Aorta | 1 | 2008 | 2037 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 317 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2007 | 1723 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 572 | 0.040 |
Why?
|
Dependovirus | 1 | 2024 | 711 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1273 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15399 | 0.040 |
Why?
|
Female | 9 | 2024 | 390323 | 0.040 |
Why?
|
Male | 7 | 2024 | 358747 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2024 | 1022 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 112 | 0.040 |
Why?
|
Postpartum Period | 1 | 2024 | 1167 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11424 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5199 | 0.030 |
Why?
|
Inflammation | 2 | 2017 | 10718 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2024 | 3380 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2666 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7199 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58683 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3072 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14354 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1174 | 0.030 |
Why?
|
Aged | 3 | 2020 | 168218 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2007 | 10416 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 248 | 0.020 |
Why?
|
Adult | 3 | 2024 | 219935 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 219568 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3602 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2018 | 2047 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9468 | 0.020 |
Why?
|
Tachycardia | 1 | 2010 | 600 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6457 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4087 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3301 | 0.020 |
Why?
|
Troponin | 1 | 2010 | 500 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8451 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14490 | 0.020 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 458 | 0.020 |
Why?
|
Vascular Patency | 1 | 2008 | 895 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12604 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2011 | 1826 | 0.010 |
Why?
|
MicroRNAs | 1 | 2020 | 3783 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2693 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2009 | 1486 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7338 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2008 | 2105 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5781 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36055 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9518 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8499 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54137 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 4429 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8553 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12951 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 58808 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(65)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_